Cyclopharm Limited (AU:CYC) has released an update.
Cyclopharm Limited has announced a notable change in director interests, with director Gregory George King acquiring 10,000 ordinary shares through an on-market trade, valued at $14,624.52. This transaction, dated June 3, 2024, marks a direct interest in the company by King, as there were no securities held by him prior to this change. There were no changes in director’s interests in contracts, and the trade did not occur during a closed period requiring prior written clearance.
For further insights into AU:CYC stock, check out TipRanks’ Stock Analysis page.
